Barclays downgrades Dr. Martens to underweight, cuts price target
In short
The investment banking firm has lowered its official investment recommendation on Dr. Martens to underweight. In conjunction with this reduced stance, the institution also decreased its price target on the company's stock. These simultaneous adjustments reflect diminished valuation expectations for the global footwear brand.
Key points
- Dr. Martens faces a less favorable investment assessment following the underweight downgr…: Dr. Martens faces a less favorable investment assessment following the underweight downgrade by Barclays.
- The reduced price target signals lowered expectations for the footwear brand's future sha…: The reduced price target signals lowered expectations for the footwear brand's future share performance.
- Market sentiment around the apparel company is expected to cool after the negative bank a…: Market sentiment around the apparel company is expected to cool after the negative bank adjustment.